Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Prediction of fibrosis progression in chronic viral hepatitis

Grace Lai-Hung Wong

Clin Mol Hepatol. 2014;20(3):228-236. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.228

View: 13137 Download: 98 Web of Science: 36 Crossref: 36

Original Article

The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data

Won Ki Hong, Moon Young Kim, Soon Koo Baik, Seung Yong Shin, Jung Min Kim, Yong Seok Kang, Yoo Li Lim, Young Ju Kim, Youn Zoo Cho, Hye Won Hwang, Jin Hyung Lee, Myeong Hun Chae, Hyoun A Kim, Hye Won Kang, Sang Ok Kwon

Clin Mol Hepatol. 2013;19(4):370-375. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.370

View: 8144 Download: 102 Crossref: 42

Review

Clinical applications of transient elastography

Kyu Sik Jung, Seung Up Kim

Clin Mol Hepatol. 2012;18(2):163-173. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.163

View: 11620 Download: 121 Crossref: 78

3

Clinical factors influencing Liver stiffness as measured by transient elastography (FibroscanⓇ) in patients with chronic Liver disease

Rack Cheon Bae, M.D., Han Jin Cho, M.D., Jong Taek Oh, M.D., Eung Kap Lee, M.D., Jun Heo, M.D., Keun Young Shin, M.D., Soo Young Park, M.D., Min Kyu Jeong, M.D., Seong Woo Jeon, M.D., Chang Min Cho, M.D., Won Young Tak, M.D., Young Oh Kweon, M.D.

Clin Mol Hepatol. 2010;16(2):123-130. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.123

View: 5194 Download: 58 Crossref: 8

Usefulness of Liver stiffness measurement for predicting the presence of esophageal varices in patients with Liver cirrhosis

Hyuk Sang Jung, M.D., Yun Soo Kim, M.D., Oh Sang Kwon, M.D., Yang Suh Ku, M.D., Yu Kyung Kim, M.D., Duck Joo Choi, M.D., Ju Hyun Kim, M.D.

Clin Mol Hepatol. 2008;14(3):342-350. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.342

View: 5078 Download: 57 Crossref: 11

1 |

Viewed By 5332	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5281	MAFLD: How is it different from NAFLD?
Viewed By 5163	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3875	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3823	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search